These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23399605)

  • 1. [Insights into melanoma from a pathologist's perspective].
    Mihic-Probst D; Beer M
    Praxis (Bern 1994); 2013 Feb; 102(4):219-24. PubMed ID: 23399605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnostics in melanoma.
    Carlson JA; Ross JS; Slominski A; Linette G; Mysliborski J; Hill J; Mihm M
    J Am Acad Dermatol; 2005 May; 52(5):743-75; quiz 775-8. PubMed ID: 15858465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure.
    Karram S; Novy M; Saroufim M; Loya A; Taraif S; Houreih MA; Rauscher B; Habib RH; Oberkanins C; Khalifeh I
    Am J Dermatopathol; 2013 Jun; 35(4):412-8. PubMed ID: 23051629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in melanoma histopathology and diagnosis.
    Piris A; Mihm MC
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):467-80, viii. PubMed ID: 19464597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What sentinel node biopsy in patients with melanoma (or patients whose doctors worry that they could have melanoma) might and might not do.
    LeBoit PE
    Clin Dermatol; 2009; 27(6):588-93. PubMed ID: 19880045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is BRAF a prognostic factor in stage III skin melanoma? A retrospective study of 72 patients after positive sentinel lymph node dissection.
    Picard M; Pham Dang N; D'Incan M; Mansard S; Dechelotte P; Pereira B; Mondie JM; Barthelemy I
    Br J Dermatol; 2014 Jul; 171(1):108-14. PubMed ID: 24602025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversial issues on melanoma.
    Lotti T; Bruscino N; Hercogova J; de Giorgi V
    Dermatol Ther; 2012; 25(5):458-62. PubMed ID: 23046025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients.
    Schlaak M; Bajah A; Podewski T; Kreuzberg N; von Bartenwerffer W; Wardelmann E; Merkelbach-Bruse S; Büttner R; Mauch C; Kurschat P
    Br J Dermatol; 2013 Apr; 168(4):708-16. PubMed ID: 23528057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic counseling and DNA testing in patients with increased risks for malignant melanoma].
    Itin PH; Fistarol SK
    Ther Umsch; 2003 Aug; 60(8):469-72. PubMed ID: 14502854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant melanoma -- a medical students' viewpoint].
    Felcht M; Fischer JC; Michels M; Weinhold M; Zouboulis CC
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):421-30. PubMed ID: 15892844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis.
    Zerp SF; van Elsas A; Peltenburg LT; Schrier PI
    Br J Cancer; 1999 Feb; 79(5-6):921-6. PubMed ID: 10070891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents.
    Roaten JB; Partrick DA; Pearlman N; Gonzalez RJ; Gonzalez R; McCarter MD
    J Pediatr Surg; 2005 Jan; 40(1):232-5. PubMed ID: 15868590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual variants of malignant melanoma.
    Barnhill RL; Gupta K
    Clin Dermatol; 2009; 27(6):564-87. PubMed ID: 19880044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical therapy of malignant melanoma of the skin].
    Bachter D
    Praxis (Bern 1994); 2001 Feb; 90(8):307-13. PubMed ID: 11256333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Genetic Evolution of Melanoma from Precursor Lesions.
    Shain AH; Yeh I; Kovalyshyn I; Sriharan A; Talevich E; Gagnon A; Dummer R; North J; Pincus L; Ruben B; Rickaby W; D'Arrigo C; Robson A; Bastian BC
    N Engl J Med; 2015 Nov; 373(20):1926-36. PubMed ID: 26559571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Malignant melanoma of the skin].
    Burg G; Dummer R; Cavegn B; Panizzon R
    Ther Umsch; 1993 Dec; 50(12):822-7. PubMed ID: 8171404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma Gene Expression Markers for Surveillance of Epidermolysis Bullosa Nevi Malignant Transformation.
    Ahn JW; Johnson K; Kohen LL; Chaffins ML; Shwayder T
    JAMA Dermatol; 2016 May; 152(5):584-6. PubMed ID: 26865206
    [No Abstract]   [Full Text] [Related]  

  • 19. Pigmented skin lesions of the upper extremity.
    Perdikis G; TerKonda SP
    Hand Clin; 2004 Aug; 20(3):283-91, vi. PubMed ID: 15275687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms.
    Avilés JA; Lázaro P; Fernández LP; Benítez J; Ibarrola-Villava M; Ribas G
    Actas Dermosifiliogr; 2012 Jan; 103(1):44-50. PubMed ID: 22464597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.